― In continuation of my update on Mipomersen... ∙ Genzyme, a Sanofi company, and Isis Pharmaceuticals Inc., announced, that the U.S. Food and Drug Administration (FDA) has accepted for filing the New Drug Application (NDA) for KYNAMRO™ (mipomersen sodium) for the treatment of patients with homozygous familial hypercholesterolemia (HoFH).....Medicinal Chemistry .
+22 more likes
A potent-smelling component of garlic oil may help release protective compounds to the ...
I am really happy to share an interesting and important article 'the secret of lowering ...
In continuation of my update on tuberculosis and drug discovery ..... A new research ...
NovaBay Pharmaceuticals, Inc. recently announced that, it is will be presenting the ...
I had every intention of posting this week's Menu Plan when I got home from my high school ...
Dulu ∙ di kantor tempat penulis kerja it ada website perusahaan yang kita ∙ ...
Depending on the age and personality of your kids, they’ll either be really ...
